Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001938319 | SCV002195424 | uncertain significance | Senior-Loken syndrome 7; Bardet-Biedl syndrome 16 | 2021-04-16 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with SDCCAG8-related conditions. This variant is present in population databases (rs774139674, ExAC 0.01%). This sequence change replaces glutamic acid with lysine at codon 240 of the SDCCAG8 protein (p.Glu240Lys). The glutamic acid residue is highly conserved and there is a small physicochemical difference between glutamic acid and lysine. |
Fulgent Genetics, |
RCV001938319 | SCV002790895 | uncertain significance | Senior-Loken syndrome 7; Bardet-Biedl syndrome 16 | 2022-03-29 | criteria provided, single submitter | clinical testing |